Perigon Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Perigon Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,961	Closed	-$166K	–	914
2024 Q1	$166K	Buy	11,961 +1,052	+10%	+$15.3K	0.01%	819
2023 Q4	$156K	Sell	10,909 -207	-2%	-$2.94K	0.01%	800
2023 Q3	$172K	Buy	+11,116	New	+$172K	0.01%	741
2021 Q1	–	Sell	-2,085	Closed	-$38K	–	970
2020 Q4	$38K	Buy	+2,085	New	+$36.6K	﹤0.01%	832

Other funds holding TAK

GAM

Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Perigon Wealth Management's TAK Position: Q2 2024 in Review

Perigon Wealth Management sold out of Takeda Pharmaceutical (TAK) in Q2 2024, closing a stake of 11,961 shares — an estimated $166K sold.

Perigon Wealth Management first reported a position in TAK in Q4 2020 and held it in 4 quarters. The position peaked at $172K in Q3 2023. 283 funds tracked by Wall St. Rank hold TAK as of Q2 2024.

Perigon Wealth Management reported no remaining Takeda Pharmaceutical position as of Q2 2024 after selling out during the quarter.
Perigon Wealth Management sold 11,961 Takeda Pharmaceutical shares in Q2 2024, an estimated $166K.
Perigon Wealth Management first reported a position in Takeda Pharmaceutical in Q4 2020 and held it in 4 quarters.
Perigon Wealth Management's Takeda Pharmaceutical position peaked at $172K in Q3 2023.
283 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2024.

Based on Perigon Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.